Recombinant Human Erythropoietin Treatment in Pre-Dialysis Patients
2020
Abstract Study Objective:To determine the efficacy and safety of recombinant human erythropoietin (r-HuEPO) in predialysis renal patients. Design:Randomized, double-blind, placebo-controlled trial ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI